AstraZeneca Pharma India files writ petition in Delhi High Court against NPPA demand notice Read more
DoP asks NPPA to review, verify Bharat Serum and Vaccine’s request of revising ceiling price of Human Normal Immunoglobulin Read more
Industry recommends changes in draft guidelines for discontinuation of scheduled formulations Read more